In this study, we found that aPKC can liberate NF‐κB (p‐P65), allowing it to enter the nucleus and thus upregulate RhoA expression to suppress glioma cells proliferation, migration, and invasion. The gene discussed is RHOA; the disease is central nervous system cancer.